news release
Glad to hear some updates. My understanding is that the pre-BTD application is a two pager so it sounds like they would get an answer reasonably quickly and then do BTD for which the response time is up to (but no more than) 60 days.
Share activity is interesting. Probably because the pool of people who have ever heard of TLT has been maxed out. I think there is simply no one new to invest who would. It's us and the regular PP participants. For those in the know with cash on the sidelines, they are probably waiting to see more as TLT's history is one of regular let-downs.
I wonder if announcing the pre-BTD is also part of lighting a fire under these mysterious large investors (the ones whose presence led to the 10 m target on the last PPs). A way of saying that the ship is leaving soon.
The data looks good as always. I really hope that they can emphasize the examples of one treatment patients who were CR for the long haul after that. No other drug has ever done that.